Johnson & Johnson's research arm, Janssen, partnered with the National Institute of Allergy and Infectious Diseases (NIAID) on the trials.
News
Weekly national news highlights for the week ending January 27, 2023.
Weekly international news highlights for the week ending January 27, 2023.
Local Pride organization engages community beyond their annual summer event.
The measure, SB 252, is the most draconian legislation to date targeting Trans people and drag performers.
A brief review of the recently elected U.S. Congress in its nascent stages, and an early outlook of what is likely to come.
A growing trend among Catholic dioceses of the United States, instituting gender identity policies causes "severe harm" and damage to Transgender and Nonbinary youth.
Weekly national news highlights for the week ending January 20, 2023.
Weekly international news highlights for the week ending January 20, 2023.
Two bills radically restricting medical care for Transgender people have been introduced in Oklahoma.